Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04112290 · ClinicalTrials.gov registry record
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
A clinical trial of Hypertrophic Cardiomyopathy, sponsored by Mayo Clinic.
- Active
- Registry status
- 260
- Enrollment target
- 1
- Study location
NCT04112290: Active study of Hypertrophic Cardiomyopathy, sponsored by Mayo Clinic.
NCT04112290 is a study of Hypertrophic Cardiomyopathy that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 260 participants, below the 1,325-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04112290, a study of Hypertrophic Cardiomyopathy, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.
Primary Outcome
Define the incidence ratio of newly diagnosed atrial fibrillation in hypertrophic cardiomyopathy, with and without sleep apnea
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2027-12 |
What the registry record for NCT04112290 still lists
NCT04112290 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,325-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Hypertrophic Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT04112290 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04112290 about?
NCT04112290 is a clinical study titled "A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy". The purpose of this research study is to understand more about various heart rhythms (electrical problems) in persons with hypertrophic cardiomyopathy with and without sleep apnea.
What is the current status of trial NCT04112290?
This trial is currently active not recruiting. The enrollment target is 260 participants. The study started on 2019-11-05. Estimated completion is 2027-12.
What conditions does trial NCT04112290 study?
This clinical trial studies the following conditions: Hypertrophic Cardiomyopathy.
Who is sponsoring clinical trial NCT04112290?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04112290 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophic Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04112290's enrollment target sits among peer trials
260 6th of 10 higher than 5 of 10 other Hypertrophic Cardiomyopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertrophic Cardiomyopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
VIZ ACCESS HCM - Multi-Site Registry
RECRUITING
-
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
RECRUITING · NA
-
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
RECRUITING · Phase 1
-
Mavacamten Pregnancy Surveillance Program
RECRUITING
-
Pediatric Cardiomyopathy Mutation Analysis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI